• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of new treatment modalities for age-related macular degeneration

Research Project

Project/Area Number 15591845
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Ophthalmology
Research InstitutionThe University of Tokyo

Principal Investigator

TAMAKI Yasuhiro  The University of Tokyo, Faculty of Medicine, Assistant Professor, 医学部附属病院, 助教授 (20217178)

Co-Investigator(Kenkyū-buntansha) NAGAI Ryouzo  The University of Tokyo, Faculty of Medicine, Professor, 医学部附属病院, 教授 (60207975)
上 順子  東京大学, 医学部附属病院, 助手 (70345213)
村中 公正  東京大学, 医学部附属病院, 助手
Project Period (FY) 2003 – 2004
Project Status Completed (Fiscal Year 2004)
Budget Amount *help
¥3,600,000 (Direct Cost: ¥3,600,000)
Fiscal Year 2004: ¥1,000,000 (Direct Cost: ¥1,000,000)
Fiscal Year 2003: ¥2,600,000 (Direct Cost: ¥2,600,000)
KeywordsKruppel-like Factor / Neovascularization / Tissue factor pathway inhibitor-2 / animal model of retinal degeneration / laser-induced CNV / COX-2 / 加齢黄班変性 / Intestitinal Kruppel like factor
Research Abstract

Firstly, using the mice lacking one allele of the Intestinal Kruppel-like Factor (IKLF) gene (IKLF (+/-) mice). the role of IKLF was investigated in the pathological retinal neovascularization using a model of the retinopathy of prematurity (ROP). First, the retina and its vessels of the IKLF (+/-) mice were normal. Next, in the ROP model, neovascularity was decreased by 74% in the KLF-1 (+/-) mice compared to the controls (p=0.0317). IKLF is dispensable for the normal retinal vascular proliferation and but is involved in pathological retinal neovascularization in vivo
Secondly, we investigated the in vivo effects of tissue factor pathway inhibitor 2 (TFPI-2), which stimulates proliferation of retinal pigment epithelial cells, but not the proliferation of fibroblast and vascular endothelial cells in vitro, on retinal degeneration using sodium-iodate (SI) induced model in rabbits and Royal College of Surgeons (RCS) rats. The recombinant TFPI-2 (rTFPI-2)-treated eyes showed significantly … More less decrease in the relative amplitude of the c-wave than control eyes after 20mg/kg of SI was intravenously administered. Additionally, The thickness of the outer nuclear layer was significantly thicker and the vacuole in the photoreceptor layer was less frequently observed in the rTFPI-2-treated RCS rats than the controls. These findings suggest that TFPI-2 rescues SI-induced retinal degeneration in rabbits and naturally occurring retinal degeneration in RCS rats at least partly.
Lastly, we investigated the anti-angiogenic effect of etodolac, cyclooxygenase (COX)-2 specific inhibitor, which inhibit cell proliferation and tubular morphogenesis of vascular endothelial cells in a murine model of choroidal neovascularization (CNV). Oral administration of etodolac significantly inhibited the induction of CNV by grade of fluorescence leakage compared to the controls. Both CNV membrane cross-sectional area and blood vessel lumen cross-sectional area were significantly decreased. The CNV inhibition by oral administration of etodolac suggests that COX-2 is related in the induction of experimentally induced CNV in the mice. Less

Report

(3 results)
  • 2004 Annual Research Report   Final Research Report Summary
  • 2003 Annual Research Report
  • Research Products

    (26 results)

All 2004 2003 Other

All Journal Article (16 results) Book (2 results) Patent(Industrial Property Rights) (2 results) Publications (6 results)

  • [Journal Article] Transpupillary thermotherapy for treatment of exudative age-related macular degeneration in Japanese patients.2004

    • Author(s)
      Atarashi T, Tamaki Y, Inoue Y, Obata R, Muranaka K, Yanagi Y
    • Journal Title

      Eye 18

      Pages: 615-618

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Effective accumulation of polyion complex micelle to experimental choroidal neovascularization in rats.2004

    • Author(s)
      Ideta R, Yanagi Y, Tamaki Y, Tasaka F, Harada A, Kataoka K
    • Journal Title

      FEBS Lett 557

      Pages: 21-25

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Contribution of bone marrow derived cells to choroidal neovascularization.2004

    • Author(s)
      Takahashi H, Yanagi Y, Tamaki Y, Muranaka K, Usui T, Sata M.
    • Journal Title

      Biochem Biophys Res Commun 320

      Pages: 372-375

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] COX-2-selective inhibitor. etodolac. suppresses choroidal neovascularization in a mice model.2004

    • Author(s)
      Takahashi H, Yanagi Y, Tamaki Y, Uchida S, Muranaka K.
    • Journal Title

      Biochem Biophys Res Commun 325

      Pages: 461-466

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Transpupillary thermotherapy for treatment of exudative age-related macular degeneration in Japanese patients.2004

    • Author(s)
      Atarashi T, Tamaki Y, Inoue Y, Obata R, Muranaka K, Yanagi Y.
    • Journal Title

      Eye 18

      Pages: 615-618

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Effective accumulation of polyion complex micelle to experimental choroidal neovascularization in rats.2004

    • Author(s)
      Ideta R, Yanagi Y, Tamaki Y, Tasaka F, Harada A, Kataoka K.
    • Journal Title

      FEBS Lett 557

      Pages: 21-25

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] COX-2-selective inhibitor, etodolac, suppresses choroidal neovascularization in a mice model.2004

    • Author(s)
      Takahashi H, Yanagi Y, Tamaki Y, Uchida S, Muranaka K.
    • Journal Title

      Biochem Biophys Res Commun 325

      Pages: 461-466

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Transpupillary theromotherapy for treatment of exudative age-related macular degeneration in Japanese patients.2004

    • Author(s)
      Atarashi T, Tamaki Y.Inoue Y.Obata R.Muranaka K.Yanagi Y
    • Journal Title

      Eye 18

      Pages: 615-618

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Effestive accumulation of polyion complex micelle to experimental choroidal neovascularization in rats2004

    • Author(s)
      Ideta R.Yanagi Y.Tamaki Y.Tasaka F.Harada A.Kataoka K.
    • Journal Title

      FEBS Lett 557

      Pages: 21-25

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Contribution of bone marrow derived cells to choroidal neovascularization.2004

    • Author(s)
      Takahashi H.Yanagi Y.Tamaki Y.Muranaka K.Usui T.Sata M.
    • Journal Title

      Biochem Biophys Commun 320

      Pages: 372-375

    • Related Report
      2004 Annual Research Report
  • [Journal Article] COX-2-selective inhibitor. etodolac. suppresses choroidal neovascularization in a mice model.2004

    • Author(s)
      Takahashi H.Yanagi Y.Tamaki Y.Uchida S.Muranaka K.
    • Journal Title

      Biochem Biophys Res Commun 325

      Pages: 461-466

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Subconjunctival doxifluridine administration suppresses rat choroidal neovascularization through activated thymidine phosphorylase.2003

    • Author(s)
      Yanagi Y, Tamaki Y.Inoue Y, Obata R, Muranaka K, Homma N
    • Journal Title

      Invest Ophthalmol Vis Sci 44

      Pages: 751-754

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Subconjunctival doxifluridine administration suppresses rat choroidal neovascularization through activated thymidine phosphorylase.2003

    • Author(s)
      Yanagi Y, Tamaki Y, Inoue Y, Obata R, Muranaka K, Homma N.
    • Journal Title

      Invest Ophthalmol Vis Sci 44

      Pages: 751-754

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Retinal degeneration is delayed by tissue factor pathway inhibitor-2 in RCS rats and sodium-iodate induced model in rabbits.

    • Author(s)
      Obata R, Yanagi Y, Tamaki Y, Hozumi K, Mutoh M, Tanaka Y.
    • Journal Title

      Eye (印刷中)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Retinal degeneration is delayed by tissue factor pathway inhibitor-2 in RCS rats and sodium-iodate induced model in rabbits.

    • Author(s)
      Obata R, Yanagi Y, Tamaki Y, Hozumi K, Mutoh M, Tanaka Y.
    • Journal Title

      Eye (in press)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Retinal degeneration is delayed by tissue factor pathway inhibitor-2 in RCS rats and sodium-iodate induced model in rabbits.

    • Author(s)
      Obata R.Yanagi Y.Tamaki Y.Hozumi K.Mutoh M.Tanaka Y.
    • Journal Title

      Eye 印刷中

    • Related Report
      2004 Annual Research Report
  • [Book] Focus on macular degeneration research.2004

    • Author(s)
      Dimitrova G, Tamaki Y
    • Total Pages
      321
    • Publisher
      Nova Science Publishers, New York
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Book] Focus on macular degeneration research2004

    • Author(s)
      Dimitrova G, Tamaki Y
    • Total Pages
      321
    • Publisher
      Nova Science Publishers, New York
    • Related Report
      2004 Annual Research Report
  • [Patent(Industrial Property Rights)] 温度上昇効果測定装置、温熱治療装置、及び治療用レーザ光の制御方法2003

    • Inventor(s)
      玉置 泰裕, 小畑 亮
    • Industrial Property Rights Holder
      玉置 泰裕, 小畑 亮
    • Filing Date
      2003-04-30
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Patent(Industrial Property Rights)] 温度上昇効果測定装置、温熱治療装置、及び治療用レーザ光の制御方法2003

    • Inventor(s)
      玉置 泰裕, 小畑 亮
    • Industrial Property Rights Holder
      玉置 泰裕, 小畑 亮
    • Filing Date
      2003-04-30
    • Related Report
      2004 Annual Research Report
  • [Publications] Yanagi Y, Tamaki Y, Inoue Y, Obata R, Muranaka K, Homma N: "Subconjunctival doxifluridine administration suppresses rat choroidal neovascul arization throughactivated thymidine phosphorylase."Invest Ophthalmol Vis Sci. 44. 751-754 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Yanagi Y, Tamaki Y, Fukushima H: "Fine retinal crystalline deposits observed by confocal scanning laser ophthalmoscopic examination using infrared light."Br J Ophthalmol. 87. 509-510 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Yanagi Y, Tamaki Y, Sekine H: "Fluorescein angiography-guided indocyanine green angiography for the detection of feeder vessels in subfoveal choroidal neovascularization."Eye. (In press).

    • Related Report
      2003 Annual Research Report
  • [Publications] Ideta R, Yanagi Y, Tamaki Y, Tasaka F, Harada A, Kataoka K: "Effective accumulation of polyion complex micelle to experimental choroidal neovascularization in rats."Febs Letters. 557. 21-25 (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] Atarashi T, Tamaki Y, Inoue Y, Obata R, Muranaka K, Yanagi Y: "Transpupillary thermotherapy for treatment of exudative age-related macular degeneration in Japanese patients."Eye. (In press). (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] Iriyama A, Uchida S, Yanagi Y, Tamaki Y, Inoue Y, Matsuura K, Kadonosono: "Effects of indocyanine green on retinal ganglion cells."Invest Ophthalmol Vis Sci. 45. 943-947 (2004)

    • Related Report
      2003 Annual Research Report

URL: 

Published: 2003-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi